Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,135 signal articles · 170 in last 24h · 159,358 total before filter · latest 21m ago
170last 24h
901last 7d
128● bullish (7d)
86● bearish (7d)
214publishers
AllMacro195Earnings194M&A94Regulatory16Product18Analyst29
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
DraftKings Q1 Earnings Call Highlights
MarketBeat145d agoneutral
DraftKings Q1 Earnings Call Highlights

DraftKings (NASDAQ:DKNG) reported first-quarter 2026 results that exceeded management’s expectations, driven by continued strength in its core Sportsbook business and an increasing push into sports predictions. First-quarter results and updated cadence commentary Co-founder and CEO Jason Robins sai

Morgan Stanley drops massive AMD stock price target after earnings
TheStreet145d agobearish
Morgan Stanley drops massive AMD stock price target after earnings

You know that feeling when you've been backing a friend's idea for months, and then suddenly the whole room starts paying attention? That's roughly where Morgan Stanley finds itself with Advanced Micro Devices (AMD). For the better part of six months, the firm had been quietly bullish on AMD's ...

What CoreWeave's Q1 earnings mean for Nvidia
Yahoo Finance Video145d agoneutralVIDEO
What CoreWeave's Q1 earnings mean for Nvidia

CoreWeave (CRWV) reported first quarter results on Thursday and missed Wall Street's guidance expectations. EMJ Capital founder and president Eric Jackson and Yahoo Finance Senior Business Reporter Ines Ferré chat with Yahoo Finance's Brian Sozzi about the earnings results and the outlook for Nvidia (NVDA) and artificial intelligence (AI) demand.

Cloudflare shares tumble on weak guidance, AI-driven restructuring
Proactive145d agobearish
Cloudflare shares tumble on weak guidance, AI-driven restructuring

Cloudflare (NYSE:NET) reported first-quarter 2026 results on May 7, beating analyst expectations for both revenue and earnings, but shares fell sharply after the company issued softer near-term guidance and announced a significant restructuring tied to an AI-focused operating model...

Investing.com145d agoneutral
Analysts cut Trade Desk ratings after weak Q2 guidance signals growth slowdown

Investing.com -- The Trade Desk was hit with downgrades from three Wall Street firms on Thursday after the digital advertising platform's second-quarter guidance came in below expectations, raising fears of a sustained deceleration in growth amid agency tensions, competitive pressures, and Middle East-related ad spending headwinds.

Trade Desk Tumbles 13%, AppLovin Holds Gains as Ad-Tech Q1 Earnings Split Wall Street
24/7 Wall St.145d agobearish
Trade Desk Tumbles 13%, AppLovin Holds Gains as Ad-Tech Q1 Earnings Split Wall Street

Shares of The Trade Desk (NASDAQ:TTD) are down roughly 13% to $20.41 in early Friday trading after the company posted a Q1 2026 earnings miss and issued a softer Q2 2026 outlook than the Street had hoped to see. The stock closed Thursday at $23.49, already down 38% year to date (YTD) heading into the ... Trade Desk Tumbles 13%, AppLovin Holds Gains as Ad-Tech Q1 Earnings Split Wall Street

Gilead (GILD) Q1 2026 Earnings Call Transcript
Motley Fool145d agoneutral
Gilead (GILD) Q1 2026 Earnings Call Transcript

As we execute on the strongest pipeline in our history, Gilead Sciences, Inc. is also taking steps to further strengthen the company's position for the future. The ongoing success of the Esthugo launch is a key driver of this growth in HIV prevention, with first quarter sales growing 72% sequentially. Looking forward, with no major LOEs until 2036, Gilead Sciences, Inc.'s HIV business is poised for strong, durable growth supported by up to seven potential new HIV product launches by 2033.